Results 201 to 210 of about 64,944 (323)

Highly Sensitive Bioluminescence Imaging Models for Chagas Disease Drug Discovery [PDF]

open access: gold, 2017
John M. Kelly   +4 more
openalex   +1 more source

Genome‐Wide CRISPR Screen Reveals PIK3CA Inhibition Enhances Lipid Nanoparticle‐Mediated siRNA Delivery

open access: yesAdvanced Science, EarlyView.
A genome‐wide CRISPR screen and identifies PIK3CA as a key regulator of lipid nanoparticle (LNP) uptake is performed. Modulating PIK3CA with small‐molecule inhibitor BAY1082439 enhanced LNP uptake, siRNA delivery, and gene silencing in a variety of epithelial cells, and improved therapeutic outcomes in vivo.
Wenhan Wang, Kangfu Chen, Zongjie Wang
wiley   +1 more source

In vivo bioluminescence imaging of granzyme B activity in tumor response to cancer immunotherapy. [PDF]

open access: yesCell Chem Biol, 2022
Chen M   +10 more
europepmc   +1 more source

A Simplified Three‐Tailed N‐Alkyl Phosphoramidate Lipid Platform Enables Inguinal Adipose‐Accumulated mRNA Delivery for Anti‐Obesity Therapy

open access: yesAdvanced Science, EarlyView.
This study develops an mRNA therapy encoding a long‐acting GLP‐1/FGF21 fusion protein. A three‐tailed ionizable lipid engineered three‐component lipid nanoparticle delivers the mRNA to inguinal adipose tissue. In obese mice, this targeted, dual‐hormone treatment potently reduces body weight, fat mass, presenting a localized strategy for metabolic ...
Bin Ma   +10 more
wiley   +1 more source

Fluorescent Protein Chromophore-Based Luciferins for Bioluminescence Imaging. [PDF]

open access: yesChem Biomed Imaging
Mangubat-Medina AE   +5 more
europepmc   +1 more source

In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin. [PDF]

open access: yesCell Chem Biol, 2023
Gonciarz RL   +10 more
europepmc   +1 more source

Engineered Small Extracellular Vesicles Targeting Tumor‐Associated Endothelial Cells to Effectively Remodel the Glioma Microenvironment

open access: yesAdvanced Science, EarlyView.
This study developed a novel drug delivery platform that overcomes the blood‐brain barrier in glioblastoma. By fusing IGFBP7 with small extracellular vesicles, the platform specifically targets tumor vasculature. It effectively delivers temozolomide, suppressing tumor growth at low doses.
Lingling Liu   +17 more
wiley   +1 more source

Immune Response to Bioluminescence Imaging Reporters in Murine Tumor Models. [PDF]

open access: yesMol Imaging Biol
Basnet A   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy